CA3137903A1 - Engineered cas9 with broadened dna targeting range - Google Patents

Engineered cas9 with broadened dna targeting range Download PDF

Info

Publication number
CA3137903A1
CA3137903A1 CA3137903A CA3137903A CA3137903A1 CA 3137903 A1 CA3137903 A1 CA 3137903A1 CA 3137903 A CA3137903 A CA 3137903A CA 3137903 A CA3137903 A CA 3137903A CA 3137903 A1 CA3137903 A1 CA 3137903A1
Authority
CA
Canada
Prior art keywords
sacas9
sequence
protein
amino acid
pam
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3137903A
Other languages
English (en)
French (fr)
Inventor
Le Cong
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leland Stanford Junior University
Original Assignee
Leland Stanford Junior University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leland Stanford Junior University filed Critical Leland Stanford Junior University
Publication of CA3137903A1 publication Critical patent/CA3137903A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/52—Genes encoding for enzymes or proenzymes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y301/00—Hydrolases acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
CA3137903A 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range Pending CA3137903A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962838498P 2019-04-25 2019-04-25
US62/838,498 2019-04-25
PCT/US2020/029855 WO2020219908A1 (en) 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range

Publications (1)

Publication Number Publication Date
CA3137903A1 true CA3137903A1 (en) 2020-10-29

Family

ID=72941444

Family Applications (1)

Application Number Title Priority Date Filing Date
CA3137903A Pending CA3137903A1 (en) 2019-04-25 2020-04-24 Engineered cas9 with broadened dna targeting range

Country Status (12)

Country Link
US (1) US20220204954A1 (cg-RX-API-DMAC7.html)
EP (1) EP3958914A4 (cg-RX-API-DMAC7.html)
JP (1) JP2022530055A (cg-RX-API-DMAC7.html)
KR (1) KR20220025708A (cg-RX-API-DMAC7.html)
CN (1) CN114206394A (cg-RX-API-DMAC7.html)
AU (1) AU2020261071A1 (cg-RX-API-DMAC7.html)
BR (1) BR112021021306A2 (cg-RX-API-DMAC7.html)
CA (1) CA3137903A1 (cg-RX-API-DMAC7.html)
IL (1) IL287541A (cg-RX-API-DMAC7.html)
MX (1) MX2021012966A (cg-RX-API-DMAC7.html)
SG (1) SG11202111814XA (cg-RX-API-DMAC7.html)
WO (1) WO2020219908A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3204496A1 (en) 2014-10-10 2017-08-16 Editas Medicine, Inc. Compositions and methods for promoting homology directed repair
AU2019291918B2 (en) 2018-06-29 2025-06-12 Editas Medicine, Inc. Synthetic guide molecules, compositions and methods relating thereto
US20230295611A1 (en) * 2022-03-01 2023-09-21 Versitech Limited Cas9 protein for genome editing
CN115083532B (zh) * 2022-06-21 2024-08-27 中国科学技术大学 基于分子动力学模拟获取rsv f突变体的方法
CN115927439B (zh) * 2022-08-29 2026-04-21 中国农业科学院作物科学研究所 CRISPR/SaCas9系统在大豆基因编辑中的应用
AU2024309386A1 (en) 2023-06-30 2025-12-18 Christiana Care Gene Editing Institute, Inc. Nras gene knockout for treatment of cancer
CN117866926B (zh) * 2024-03-07 2024-08-16 珠海舒桐医疗科技有限公司 一种CRISPR-FrCas9蛋白突变体及应用
WO2025213016A2 (en) 2024-04-04 2025-10-09 Christiana Care Gene Editing Institute, Inc. Crispr/cas gene editing of neh4 and/or neh5 domains in nrf2
WO2025226816A1 (en) 2024-04-23 2025-10-30 Christiana Care Gene Editing Institute, Inc. Methods of identifying and correlating crispr-induced exon skipping to phenotypic outcomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2016226077B2 (en) * 2015-03-03 2021-12-23 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases with altered PAM specificity
WO2016205759A1 (en) * 2015-06-18 2016-12-22 The Broad Institute Inc. Engineering and optimization of systems, methods, enzymes and guide scaffolds of cas9 orthologs and variants for sequence manipulation
US9512446B1 (en) * 2015-08-28 2016-12-06 The General Hospital Corporation Engineered CRISPR-Cas9 nucleases
WO2018027078A1 (en) * 2016-08-03 2018-02-08 President And Fellows Of Harard College Adenosine nucleobase editors and uses thereof
KR102569848B1 (ko) * 2016-12-23 2023-08-25 프레지던트 앤드 펠로우즈 오브 하바드 칼리지 Pcsk9의 유전자 편집
JP6628387B2 (ja) * 2017-09-05 2020-01-08 国立大学法人 東京大学 改変されたCas9タンパク質及びその用途

Also Published As

Publication number Publication date
MX2021012966A (es) 2022-04-06
CN114206394A (zh) 2022-03-18
AU2020261071A1 (en) 2021-11-25
US20220204954A1 (en) 2022-06-30
EP3958914A4 (en) 2023-07-19
BR112021021306A2 (pt) 2022-02-01
WO2020219908A1 (en) 2020-10-29
KR20220025708A (ko) 2022-03-03
SG11202111814XA (en) 2021-11-29
EP3958914A1 (en) 2022-03-02
IL287541A (en) 2021-12-01
JP2022530055A (ja) 2022-06-27

Similar Documents

Publication Publication Date Title
US20220204954A1 (en) Engineered cas9 with broadened dna targeting range
Tou et al. Precise cut-and-paste DNA insertion using engineered type VK CRISPR-associated transposases
Sharon et al. Functional genetic variants revealed by massively parallel precise genome editing
Cerbin et al. Duplication of host genes by transposable elements
Babu et al. Bridge helix of Cas9 modulates target DNA cleavage and mismatch tolerance
Yagi et al. Elucidation of the RNA recognition code for pentatricopeptide repeat proteins involved in organelle RNA editing in plants
CN105408497B (zh) 使用截短的引导RNA(tru-gRNA)提高RNA引导的基因组编辑的特异性
CA3127494A1 (en) Nucleobase editors having reduced off-target deamination and methods of using same to modify a nucleobase target sequence
US9688972B2 (en) CRISPR hybrid DNA/RNA polynucleotides and methods of use
CN120944860A (zh) 胞嘧啶脱氨酶及其在碱基编辑中的用途
CN110959040A (zh) 具有改进的精度和特异性的碱基编辑器
CN110914426A (zh) 包含核酸可编程dna结合蛋白的核碱基编辑器
CN112912496A (zh) 提高氨基酸球菌属cpf1的dna切割活性的新型突变
EP4567117A2 (en) Engineered mad7 directed endonuclease
US20230091242A1 (en) Rna-guided genome recombineering at kilobase scale
WO2024017189A1 (en) Tnpb-based genome editor
WO2024178854A1 (zh) 新型TnpB编程性核酸酶及其应用
Sloan et al. Testing for selection on synonymous sites in plant mitochondrial DNA: the role of codon bias and RNA editing
Wei et al. Engineering eukaryotic transposon-encoded Fanzor2 system for genome editing in mammals
Cegan et al. Genomic diversity in two related plant species with and without sex chromosomes-Silene latifolia and S. vulgaris
Liu et al. A novel DNA methylation motif identified in Bacillus pumilus BA06 and possible roles in the regulation of gene expression
Wu et al. Two compact Cas9 ortholog-based cytosine base editors expand the DNA targeting scope and applications in vitro and in vivo
Larsen et al. Computationally optimised DNA assembly of synthetic genes
WO2024044329A1 (en) Crispr base editor
WO2024230784A1 (en) Methods and systems for identification of sequence adjacent motif, potency, and fidelity of a nuclease

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20220917